01 February 2006
Activation of genes inducing cell-cycle arrest and of increased DNA repairin the hearts of rats with early streptozotocin-induced diabetes mellitus.
Olga Golubnitschaja, Heike Moenkemann, Daniela B. Trog, Henk J. Blom, An S. De VrieseMed Sci Monit 2006; 12(2): BR68-74 :: ID: 445233
Abstract
Background: Background: Oxidative stress was proposed as a critical factorin diabetic complications. The etiology of cell degeneration in diabetes mellitus (DM)-induced cardiomyopathyis unclear. The transition between apoptotic degeneration and cell proliferation under stress conditionsis regulated at cell-cycle checkpoints. This study was aimed at elucidating the role of a potent cellularstress-response system of the p53-dependent checkpoint genes, i.e. P21(WAF1/CIP1) and 14-3-3 sigma, inthe heart in diabetes. Material/Methods: Target gene expression levels were analyzed ex vivo in cardiomyocytesof streptozotocin-induced rats by Western blots and two-dimensional immunoblots. The levels of DNA damage/repairin diabetic cardiomyocytes were evaluated by "comet assay" and compared with a control group. Results:Whereas no detectable expression of 14-3-3 sigma and only traces of both p53 and p21(WAF1/CIP1) werefound in cardiomyocytes of the controls, high expression rates of all three genes were observed in theDM group. Individual levels of DNA breakage were significantly lower in diabetic than in non-diabeticcardiomyocytes. Conclusions: We propose a dual role for cell-cycle regulation under diabetic conditions:the expressions of both p21[sup]WAF1/CIP1[/sup] and 14-3-3 sigma genes, activated via p53 function, trigger cell-cyclearrest and DNA repair, preventing replication of mutated DNA and increasing stress resistance of hearttissue at least in early diabetes. However, the double cell-cycle arrest ultimately inhibits the replicationof cells, which consequently accumulate in the G(1) and G(2) phases; this could lead to retarded proliferativeactivity and tissue degeneration in diabetic myocardium in later diabetes.
Keywords: Cell Cycle - genetics, Cardiomyopathies - pathology, Comet Assay, Cyclin-Dependent Kinase Inhibitor p21 - genetics, DNA Repair - genetics, Diabetes Mellitus, Experimental - pathology, Gene Expression Regulation, Genes, p53, Myocardium - pathology, Myocytes, Cardiac - pathology, Rats, Wistar
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Preoperative Blood Transfusion Requirements for Hemorrhoidal Severe Anemia: A Retrospective Study of 128 Pa...Med Sci Monit In Press; DOI: 10.12659/MSM.943126
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952